Table A3.
Adjuvant Therapy | Events (deaths), No. | Median Survival, Months (95% CI) | 5-Year Survival, % (95% CI) |
---|---|---|---|
None | 243 of 388 | 42.1 (34.0 to 51.8) | 40.4 (35.2 to 45.5) |
Chemotherapy | 188 of 354 | 59.8 (50.8 to 71.1) | 50.0 (44.2 to 55.3) |
Chemotherapy with radiation to brain | 37 of 99 | 88.9 (72.5 to NA) | 67.6 (56.9 to 76.2) |
Chemotherapy with radiation to lung | 52 of 87 | 43.8 (28.5 to 78.7) | 44.5 (33.6 to 54.9) |
Concurrent chemoradiation | 30 of 54 | 56.8 (31.3 to 91.5) | 48.6 (34.3 to 61.5) |
Sequential chemoradiation | 21 of 31 | 29.7 (18.7 to 95.1) | 38.2 (21.5 to 54.8) |
Radiation to lung | 11 of 17 | 37.5 (19.0 to NA) | 47.1 (23.0 to 68.0) |
NOTE. Survival data for patients who received adjuvant radiation directed at the brain was not reported as a result of a small sample size (n < 10), in accordance with the National Cancer Data Base Participant Use File Data Use Agreement.
Abbreviations: NA, not available; SCLC, small-cell lung cancer.